HLS Therapeutics Statistics
Total Valuation
HLTRF has a market cap or net worth of 113.71 million. The enterprise value is 162.02 million.
Market Cap | 113.71M |
Enterprise Value | 162.02M |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 31.63M |
Shares Outstanding | n/a |
Shares Change (YoY) | -1.10% |
Shares Change (QoQ) | +5.17% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 19.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.00 |
PB Ratio | 1.70 |
P/TBV Ratio | n/a |
P/FCF Ratio | 10.59 |
P/OCF Ratio | 10.56 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.80, with an EV/FCF ratio of 15.09.
EV / Earnings | -9.01 |
EV / Sales | 2.72 |
EV / EBITDA | 9.80 |
EV / EBIT | n/a |
EV / FCF | 15.09 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.95.
Current Ratio | 1.43 |
Quick Ratio | 1.07 |
Debt / Equity | 0.95 |
Debt / EBITDA | 4.05 |
Debt / FCF | 5.94 |
Interest Coverage | -0.68 |
Financial Efficiency
Return on equity (ROE) is -23.08% and return on invested capital (ROIC) is -2.63%.
Return on Equity (ROE) | -23.08% |
Return on Assets (ROA) | -2.28% |
Return on Invested Capital (ROIC) | -2.63% |
Return on Capital Employed (ROCE) | -4.93% |
Revenue Per Employee | 617,054 |
Profits Per Employee | -195,489 |
Employee Count | 92 |
Asset Turnover | 0.32 |
Inventory Turnover | 1.76 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.21% in the last 52 weeks. The beta is 1.03, so HLTRF's price volatility has been similar to the market average.
Beta (5Y) | 1.03 |
52-Week Price Change | +26.21% |
50-Day Moving Average | 2.76 |
200-Day Moving Average | 5.67 |
Relative Strength Index (RSI) | 64.13 |
Average Volume (20 Days) | 924 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HLTRF had revenue of 56.77 million and -17.99 million in losses. Loss per share was -0.57.
Revenue | 56.77M |
Gross Profit | 41.31M |
Operating Income | -6.41M |
Pretax Income | -13.91M |
Net Income | -17.99M |
EBITDA | 15.70M |
EBIT | -6.41M |
Loss Per Share | -0.57 |
Balance Sheet
The company has 17.73 million in cash and 63.74 million in debt, giving a net cash position of -46.01 million.
Cash & Cash Equivalents | 17.73M |
Total Debt | 63.74M |
Net Cash | -46.01M |
Net Cash Per Share | n/a |
Equity (Book Value) | 66.80M |
Book Value Per Share | 2.10 |
Working Capital | 10.23M |
Cash Flow
In the last 12 months, operating cash flow was 10.77 million and capital expenditures -34,000, giving a free cash flow of 10.73 million.
Operating Cash Flow | 10.77M |
Capital Expenditures | -34,000 |
Free Cash Flow | 10.73M |
FCF Per Share | n/a |
Margins
Gross margin is 72.78%, with operating and profit margins of -11.29% and -31.68%.
Gross Margin | 72.78% |
Operating Margin | -11.29% |
Pretax Margin | -24.50% |
Profit Margin | -31.68% |
EBITDA Margin | 27.66% |
EBIT Margin | -11.29% |
FCF Margin | 18.91% |
Dividends & Yields
HLTRF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.10% |
Shareholder Yield | n/a |
Earnings Yield | -15.82% |
FCF Yield | 9.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HLTRF has an Altman Z-Score of -0.9. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.9 |
Piotroski F-Score | n/a |